Company research
Healthcare Triangle, Inc.
CIK 1839285Updated Nov 14, 2026
SecurityHCTI · NASDAQ · equity
HCTI price & chart
Loading TradingView…
NASDAQ:HCTI on TradingView ↗About the company
Healthcare Triangle, Inc. delivers advanced digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare providers, payers, and life sciences organizations. HCTI strengthens healthcare delivery through enhanced security, compliance, data analytics, and operational efficiency.
In the news
Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity ↗
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan ↗
Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies ↗
Recent filings
10-Q filing
Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events
Items 3.03, 5.03, 8.01, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
DEF 14A filing
PRE 14A filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 13,838,000Source | 4,766,000Source | 73,640,000Source | 14,568,000Source | 6,021,000Source | 80,162,000Source | 11,785,000Source | 6,872,000Source | 22,736,000Source | 1,961,000Source | 6,858,000Source | 20,763,000Source |
| Property, Plant and Equipment, NetUSD | 5,000Source | 17,000Source | 1,192,000Source | 3,000Source | 24,000Source | 1,330,000Source | — | 33,000Source | 5,000Source | 12,000Source | 44,000Source | 80,000Source |
| GoodwillUSD | — | — | 2,946,000Source | — | — | 2,946,000Source | — | — | 2,946,000Source | — | — | 1,289,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 2,965,000Source | — | — | 3,301,000Source | — | — | 3,637,000Source | — | — | 857,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,629,000Source | 28,000Source | 1,906,000Source | — | 29,000Source | 4,315,000Source | 6,826,000Source | 301,000Source | 7,625,000Source | 20,000Source | 1,234,000Source | 1,341,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,441,000Source | 1,610,000Source | 6,186,000Source | 1,862,000Source | 2,005,000Source | 8,367,000Source | 1,907,000Source | 2,095,000Source | 2,070,000Source | 1,110,000Source | 3,595,000Source | 5,592,000Source |
| Assets, CurrentUSD | 7,942,000Source | 1,784,000Source | 9,646,000Source | 8,865,000Source | 2,333,000Source | 18,895,000Source | 9,840,000Source | 3,169,000Source | 13,151,000Source | 1,452,000Source | 5,653,000Source | 7,749,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 5,112,000Source | 6,584,000Source | 24,541,000Source | 4,359,000Source | 6,667,000Source | 27,465,000Source | 3,208,000Source | 7,383,000Source | — | 7,075,000Source | 8,249,000Source | 8,375,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | 7,435,000Source | — | — | 7,435,000Source | — | — |
| Common Stock, Value, IssuedUSD | 11,000Source | — | 11,000Source | 14,000Source | — | 11,000Source | — | 0Source | 11,000Source | — | 0Source | 0Source |
| Additional Paid in CapitalUSD | 36,818,000Source | 27,708,000Source | 65,231,000Source | 39,399,000Source | 27,631,000Source | 76,651,000Source | 36,413,000Source | 26,256,000Source | 45,534,000Source | 21,022,000Source | 26,211,000Source | 24,956,000Source |
| Retained Earnings (Accumulated Deficit)USD | -38,520,000Source | -29,526,000Source | -53,489,000Source | -36,639,000Source | -28,277,000Source | -49,339,000Source | -35,271,000Source | -26,767,000Source | -42,999,000Source | -33,571,000Source | -27,602,000Source | -12,568,000Source |
| Stockholders' Equity Attributable to ParentUSD | — | -1,818,000Source | — | 10,209,000Source | -646,000Source | — | 8,577,000Source | -2,441,000Source | — | -5,114,000Source | -1,391,000Source | 12,478,000Source |
| Liabilities and EquityUSD | 13,838,000Source | 4,766,000Source | 73,640,000Source | 14,568,000Source | 6,021,000Source | 80,162,000Source | 11,785,000Source | 6,872,000Source | 22,736,000Source | 1,961,000Source | 6,858,000Source | 20,763,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,912,000Source | 6,084,000Source | 15,990,000Source | 3,159,000Source | 6,167,000Source | 20,993,000Source | 3,208,000Source | 5,995,000Source | 12,792,000Source | 7,075,000Source | 7,652,000Source | 6,148,000Source |
| Accounts Payable, CurrentUSD | 1,308,000Source | 2,298,000Source | 1,199,000Source | 2,074,000Source | 1,937,000Source | 3,288,000Source | 1,618,000Source | 2,013,000Source | 744,000Source | 2,539,000Source | 1,953,000Source | 1,481,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -18,000Source | — | -89,000Source | — | — | -61,000Source | — | — | -37,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | — | — | — | — | — | — | — | — | 5,592,000Source |
| Operating Lease, Right-of-Use Asset | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Other Assets, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Operating Lease, Liability, Current | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Operating Lease, Liability, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Other Liabilities, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Accrued Liabilities, Current | — | — | — | — | — | —Source | — | — | — | — | — | — |
| Long-term Debt | — | — | —Source | — | — | —Source | — | —Source | — | — | — | — |
| Long-term Debt, Current Maturities | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -401,000Source | -9,609,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 810,000Source | 12,000Source | 705,000Source | 889,000Source | 1,566,000Source | 3,374,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 36,000Source | 451,000Source | 87,000Source | 166,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 1,542,000Source | 797,000Source | 913,000Source | -2,315,000Source | -2,270,000Source | -4,081,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,864,000Source | -5,557,000Source | -16,523,000Source | -1,081,000Source | -2,151,000Source | -2,600,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -6,022,000Source | — | -1,751,000Source | — | -12,000Source | -3,319,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 22,000Source | — | 6,000Source | — | 12,000Source | — |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 142,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 9,478,000Source | 12,363,000Source | 25,879,000Source | -133,000Source | 2,056,000Source | 5,490,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,629,000Source | 28,000Source | 1,906,000Source | 3,228,000Source | 4,315,000Source | 6,826,000Source | 7,625,000Source | 20,000Source | 1,234,000Source | 1,341,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 413,000Source | — | 121,000Source | 968,000Source | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | 12,000Source | 35,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 451,000Source | 0Source | — | 257,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | 223,000Source | 223,000Source | — | 435,000,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 857,000Source | 1,518,000Source | 3,167,000Source |
| AssetAcquisitionContingentConsiderationLiabilityUSD | — | — | — | — | — | — | — | — | — | — | — | 2,227,000Source |
| DepreciationUSD | — | — | 5,000Source | 7,000Source | 153,000Source | 0Source | 163,000Source | 12,000Source | 13,000Source | 32,000Source | 48,000Source | 35,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | 41,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -14,000Source | — | -17,000Source | — | -63,000Source | — | -18,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 2,085,000Source | 1,077,000Source | 4,821,000Source | 1,182,000Source | 3,217,000Source | 1,198,000Source | 7,337,000Source | 3,950,000Source | 5,727,000Source | 5,575,000Source |
| GoodwillUSD | — | — | — | — | 2,946,000Source | — | 2,946,000Source | — | 2,946,000Source | — | — | 1,289,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 2,385,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | 3,623,000Source | — | 9,789,000Source | — | — | -10,414,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -18,000Source | — | -28,000Source | — | -24,000Source | — | -37,000Source | — | -35,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | 2,000Source | 24,000Source | — | — | — | — | 12,000Source | 35,000Source | 63,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,906,000Source | -1,249,000Source | -4,415,000Source | -1,367,000Source | -6,198,000Source | -1,700,000Source | -9,476,000Source | -5,969,000Source | -8,686,000Source | -9,610,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -24,000Source | — | -37,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 1,906,000Source | 1,249,000Source | -4,150,000Source | -1,367,000Source | -6,340,000Source | -1,700,000Source | 9,428,000Source | — | -8,686,000Source | -9,609,000Source |
| Operating ExpensesUSD | — | — | 3,209,000Source | 1,889,000Source | 6,138,000Source | 1,853,000Source | 6,016,000Source | 1,727,000Source | 11,679,000Source | 7,641,000Source | 14,472,000Source | 21,711,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 484,000Source | — | 9,825,000Source | — | 500,000Source | 5,888,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 29,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | — | — | — | — | 125,000Source | — | 17,000Source | — | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | — | 45,886,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | 27,000Source | — | — | — |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation, Nonproduction | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | —Source | — | — | — | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Proceeds from Contributed Capital | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 3,489,000Source | 2,413,000Source | 9,193,000Source | 3,558,000Source | 9,855,000Source | 3,704,000Source | 13,891,000Source | 11,696,000Source | 33,203,000Source | 45,886,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Operating Income (Loss)USD | — | — | -2,591,000Source | -1,167,000Source | -4,071,000Source | -1,359,000Source | -3,623,000Source | -1,398,000Source | -9,789,000Source | -4,751,000Source | -7,695,000Source | -10,416,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,906,000Source | -1,247,000Source | -4,391,000Source | -1,367,000Source | -6,198,000Source | -1,700,000Source | -9,476,000Source | -5,957,000Source | -8,651,000Source | -9,547,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | 2,000Source | 24,000Source | — | — | — | — | 12,000Source | 35,000Source | 63,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -24,000Source | — | -37,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,906,000Source | -1,249,000Source | -4,415,000Source | -1,367,000Source | -6,198,000Source | -1,700,000Source | -9,476,000Source | -5,969,000Source | -8,686,000Source | -9,610,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.42Source | -54.78Source | -1.56Source | -35.01Source | -6.81Source | -0.17Source | -152.3Source | -1.13Source | -2.08Source | — |
| Earnings Per Share, DilutedUSD per share | — | — | -0.42Source | -54.78Source | -1.56Source | -35.01Source | -6.81Source | -0.17Source | -152.3Source | -1.13Source | -2.08Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 4,443,784Source | 22,756Source | 2,805,546Source | 39,057Source | 930,672Source | 659Source | 61,873Source | 5,278,293Source | 4,179,140Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 4,443,784Source | 22,756Source | 2,805,546Source | 39,057Source | 930,672Source | 659Source | 61,873Source | 5,278,293Source | 4,179,140Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 857,000Source | 1,518,000Source | 3,167,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | 0Source | 63,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 63,000Source | 343,000Source | 529,000Source | — | 810,000Source | 12,000Source | 705,000Source | — | 1,566,000Source | 3,374,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | 41,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -14,000Source | — | -17,000Source | — | -63,000Source | — | -18,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 2,085,000Source | 1,077,000Source | 4,821,000Source | 1,182,000Source | 3,217,000Source | 1,198,000Source | 7,337,000Source | 3,950,000Source | 5,727,000Source | 5,575,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 2,385,000Source | — |
| Gross ProfitUSD | — | — | — | — | 2,067,000Source | 494,000Source | — | 1,070,000,000Source | 1,235,000,000Source | 1,070,000,000Source | 1,070,000,000Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | — | — | — | -8,651,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | 3,623,000Source | — | 9,789,000Source | — | — | -10,414,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -18,000Source | — | -28,000Source | — | -24,000Source | — | -37,000Source | — | -35,000Source | — |
| Interest ExpenseUSD | — | — | — | -80,000Source | — | — | 89,000Source | — | 567,000Source | — | — | 212,000Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | 968,000Source | 211,000Source |
| Interest Income (Expense), NetUSD | — | — | -32,000Source | -80,000Source | -89,000Source | -21,000Source | -85,000Source | -413,000Source | -567,000Source | -1,213,000Source | -968,000Source | -212,000Source |
| Marketing and Advertising ExpenseUSD | — | — | 649,000Source | 78,000Source | — | 236,000Source | — | — | — | — | — | 6,808,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 1,906,000Source | 1,249,000Source | -4,150,000Source | -1,367,000Source | -6,340,000Source | -1,700,000Source | 9,428,000Source | — | -8,686,000Source | -9,609,000Source |
| Operating ExpensesUSD | — | — | 3,209,000Source | 1,889,000Source | 6,138,000Source | 1,853,000Source | 6,016,000Source | 1,727,000Source | 11,679,000Source | 7,641,000Source | 14,472,000Source | 21,711,000Source |
| Other ExpensesUSD | — | — | — | — | — | — | — | — | 1,215,000Source | — | — | — |
| Other IncomeUSD | — | — | 731,000Source | — | 438,000Source | 13,000Source | 8,000Source | 111,000Source | 857,000Source | 7,000Source | 12,000Source | 1,081,000Source |
| Research and Development ExpenseUSD | — | — | 59,000Source | 175,000Source | 51,000Source | 55,000Source | 85,000Source | 144,000Source | 536,000Source | 429,000Source | 799,000Source | 5,953,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | — | 45,886,000Source |
| Selling and Marketing ExpenseUSD | — | — | 1,022,000Source | 294,000Source | 720,000Source | 616,000Source | 1,779,000Source | 373,000Source | 3,084,000Source | 2,203,000Source | 4,670,000Source | — |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Direct Costs of Leased and Rented Property or Equipment | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-297397
Registration 333-297283
Filing attachments
ea030971601ex99-1.htm · 8-K · 2026-10-27
Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI ) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that it will effect a 1-for-20 reverse stock split of its common stock. The reverse stock sp…
Read attachment ↗ea029955101ex99-1.htm · 8-K · 2026-07-29
EX-99.1 2 ea029955101ex99-1.htm PRICING PRESS RELEASE DATED JULY 29, 2026 Exhibit 99.1 Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq’s New $5 Million Market Value Listing Standard Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq’s newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif. …
Read attachment ↗ea029478001ex4-1.htm · 8-K · 2026-06-15
EX-4.1 2 ea029478001ex4-1.htm FORM OF ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 12, 2026 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUAN…
Read attachment ↗ea029478001ex4-2.htm · 8-K · 2026-06-15
EX-4.2 3 ea029478001ex4-2.htm COMMON STOCK PURCHASE WARRANT ISSUED TO HUDSON GLOBAL VENTURES, LLC, DATED JUNE 12, 2026 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS…
Read attachment ↗ea029478001ex99-1.htm · 8-K · 2026-06-15
EX-99.1 7 ea029478001ex99-1.htm PRESS RELEASE, DATED JUNE 12, 2026 Exhibit 99.1 Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million PLEASANTON, Calif., June 12, 2026 (PR NEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of…
Read attachment ↗ea028419101ex4-4.htm · 10-K · 2026-04-15
Exhibit 4.4 DESCRIPTION OF CAPITAL STOCK General The following description summarizes the most important terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth in this “Description of Capital Stock,” you should refer to our amended and restated certificate of incorporation, as amended (“Certificate of Incorporation”) and amended and restated bylaws (“Bylaws”), which are…
Read attachment ↗